AstraZeneca PLC 2017 SR
The report highlights AstraZeneca's progress in 2017 across three main pillars: Access to Healthcare, Environmental Protection, and Ethics and Transparency. Key achievements include reaching 7.2 million people through access programs, achieving a 7% reduction in the operational carbon footprint, and launching a new Code of Ethics. The company also committed to sourcing 100% renewable power by 2025, with 63% already achieved in 2017. Furthermore, AstraZeneca maintained its leadership in managing pharmaceuticals in the environment and expanded its Young Health Programme to 12 active markets.
Company: AstraZeneca PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2017
Type: SR
Pages: 59
Back to company
AstraZeneca PLC
Sustainability Report
The report highlights AstraZeneca's progress in 2017 across three main pillars: Access to Healthcare, Environmental Protection, and Ethics and Transparency. Key achievements include reaching 7.2 million people through access programs, achieving a 7% reduction in the operational carbon footprint, and launching a new Code of Ethics. The company also committed to sourcing 100% renewable power by 2025, with 63% already achieved in 2017. Furthermore, AstraZeneca maintained its leadership in managing pharmaceuticals in the environment and expanded its Young Health Programme to 12 active markets.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management